Stanley M. Bergman will retire as CEO of Henry Schein at the end of 2025, concluding a 45-year tenure that included more than 35 years as CEO. He will remain chair of the board after stepping down. The company has begun a formal search for his successor, considering both internal and external candidates.
Under Bergman’s leadership, Henry Schein grew revenues from $225 million in 1989 to nearly $13 billion in 2024, with a compound annual growth rate of approximately 17.5%. The company went public in 1995 and now holds a $9 billion market capitalization. Bergman transformed Henry Schein from a U.S.-based dental mail-order firm into a global leader in dental and medical product distribution, emphasizing public-private partnerships to improve care access.
Bergman expressed gratitude for his career at Henry Schein and confidence in the company’s future.
Follow MEDWIRE.AI for executive leadership and industry updates.
